M&A Deal Summary |
|
|---|---|
| Date | 2024-05-01 |
| Target | KCRI |
| Sector | Life Science |
| Buyer(s) | Alcanza Clinical Research |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2021 |
| Sector | Life Science |
Alcanza Clinical Research is an integrated network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities. Alcanza Clinical Research was founded in 2021 and is based in Lake Mary, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 6 |
| Sector: Life Science M&A | 3 of 4 |
| Type: Add-on Acquisition M&A Deals | 5 of 6 |
| State: Missouri M&A | 1 of 1 |
| Country: United States M&A | 4 of 5 |
| Year: 2024 M&A | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-22 |
FDI Clinical Research
San Juan, Puerto Rico FDI Clinical Research is a multi-specialty research organization specializing in Phase I-IV trials across endocrine and metabolic conditions, immunology, hepatology, infectious diseases, oncology, respiratory, and rheumatology. FDI Clinical Research was founded in 2002 and is based in San Juan, Puerto Rico. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-06-03 |
North Georgia Clinical Research
Woodstock, Georgia, United States North Georgia Clinical Research is a research provider that specializes in general medicine studies involving Alzheimer's disease prevention, cardiovascular disease, diabetes, digestive conditions, pain, as well as men's and women's health indications. NGCR was formed in 2002 and is headquartered in Woodstock, Georgia. |
Buy | - |
